<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010165</url>
  </required_header>
  <id_info>
    <org_study_id>0916</org_study_id>
    <secondary_id>2009-A00810-57</secondary_id>
    <nct_id>NCT01010165</nct_id>
  </id_info>
  <brief_title>Determination of New Biomarkers of Septic Arthritis by Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF)</brief_title>
  <acronym>NOUBASST</acronym>
  <official_title>Caract√©risation de Nouveaux Biomarqueurs de l'Arthrite Septique Par Technique SELDI-TOF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Septic arthritis is a frequent, potentially disabling and/or life-threatening disease. To
      diagnose a septic arthritis is a complex procedure, first because of numerous differential
      diagnoses (such as crystal arthritis), second because of poor sensitivity of initial gram
      staining (for example after untimely antibiotic therapy).

      This protocol will use SELDI-TOF as a tool to analyse joint fluid of patients with various
      acute, polymorphonuclear-rich arthritis, as to determine specific and sensitive new
      biomarkers of a septic origin.

      Such biomarkers will allow rapid diagnosis of septic arthritis in the first hours of
      admission.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">89</enrollment>
  <condition>Acute Arthritis</condition>
  <arm_group>
    <arm_group_label>septic arthritis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>crystal arthritis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>rheumatismal disease</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      joint fluid proteom
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients from the Grenoble University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute arthritis (onset not more than 7 days ago)

          -  joint fluid leukocyte count : more than 2000/mm3, more than 50% polymorphonuclear

        Exclusion Criteria:

          -  none (apart from unability to accept inclusion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>olivier epaulard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2009</study_first_submitted>
  <study_first_submitted_qc>November 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2009</study_first_posted>
  <last_update_submitted>October 25, 2012</last_update_submitted>
  <last_update_submitted_qc>October 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute arthritis</keyword>
  <keyword>bacteria</keyword>
  <keyword>crystal arthritis</keyword>
  <keyword>proteomic</keyword>
  <keyword>SELDI-TOF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

